BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 3100553)

  • 1. Current strategies in operable breast cancer.
    Deckers PJ
    Hosp Pract (Off Ed); 1987 Jan; 22(1A):41-9, 53-4, 59-68. PubMed ID: 3100553
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis and therapy of breast cancer].
    Judmaier F; Manfreda D
    Wien Med Wochenschr; 1981 Dec; 131(23-24):571-4. PubMed ID: 7336750
    [No Abstract]   [Full Text] [Related]  

  • 3. [Conservative treatment of breast cancer].
    Veronesi U
    Chirurg; 1985 Apr; 56(4):269-75. PubMed ID: 3996098
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
    Botti C; Vici P; Lopez M; Scinto AF; Cognetti F; Cavaliere R
    J Am Coll Surg; 1995 Sep; 181(3):202-8. PubMed ID: 7670678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One more change of paradigm in breast cancer treatment. Postmastectomy radiotherapy for patients with one to three lymph node metastases?
    Sautter-Bihl ML; Sauer R
    Strahlenther Onkol; 2007 Jul; 183(7):357-9. PubMed ID: 17609867
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adjuvant therapy of breast cancer].
    Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
    Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of subcutaneous mastectomy with radical mastectomy.
    Horiguchi J; Iino JHY ; Takei H; Koibuchi Y; Iijima K; Ikeda F; Ochiai R; Uchida K; Yoshida M; Yokoe T; Morishita Y
    Anticancer Res; 2001; 21(4B):2963-7. PubMed ID: 11712794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative clinical, mammographic and sonographic assessment of neoadjuvant chemotherapy response in breast cancer.
    Sperber F; Weinstein Y; Sarid D; Ben Yosef R; Shalmon A; Yaal-Hahoshen N
    Isr Med Assoc J; 2006 May; 8(5):342-6. PubMed ID: 16805235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
    Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G
    Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts in the treatment of early stage breast cancer.
    Puckett C
    Del Med J; 1992 May; 64(5):313-9. PubMed ID: 1319354
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical margin and breast recurrence after breast-conserving therapy.
    Horiguchi J; Iino Y; Takei H; Maemura M; Yokoe T; Niibe H; Yamakawa M; Nakajima T; Oyama T; Morishita Y
    Oncol Rep; 1999; 6(1):135-8. PubMed ID: 9864416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ipsilateral breast tumor recurrence following conservative surgery and radiation therapy.
    DiPaola RS; Orel SG; Fowble BL
    Oncology (Williston Park); 1994 Dec; 8(12):59-68; discussion 71, 75-6. PubMed ID: 7888313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant chemotherapy in operable breast cancer].
    Senn HJ
    Dtsch Med Wochenschr; 1984 Jun; 109(26):1034-43. PubMed ID: 6734462
    [No Abstract]   [Full Text] [Related]  

  • 17. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
    Ahlgren J; Holmberg L; Bergh J; Liljegren G
    Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients.
    Cheng SH; Horng CF; Clarke JL; Tsou MH; Tsai SY; Chen CM; Jian JJ; Liu MC; West M; Huang AT; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1401-9. PubMed ID: 16472935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options.
    Gentilini O; Masullo M; Rotmensz N; Peccatori F; Mazzarol G; Smeets A; Simsek S; De Dosso S; Veronesi P; Intra M; Zurrida S; Viale G; Goldhirsch A; Veronesi U
    Eur J Surg Oncol; 2005 Apr; 31(3):232-6. PubMed ID: 15780556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
    Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB
    Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.